Vanderbilt Tuberculosis Center
Save the Date: TB Center Meeting
Tuesday, August 28, 9:00-10:00 am
A2200 Medical Center North
3HP Updated Recommendations
The Centers for Disease Control and Prevention (CDC) released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent tuberculosis (TB) infection. The updated recommendations, published in CDC’s Morbidity and Mortality Weekly Report (MMWR), support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection. 
The updated recommendations include the use of 3HP:
  • By directly observed therapy or self-administered therapy in persons over 2 years of age;
  • In children and adolescents, 2-11 years old; and
  • In persons with latent TB infection who are living with HIV/AIDS and taking antiretroviral medications with acceptable drug interactions with rifapentine.
The 3HP regimen can help remove current barriers to initiate and complete latent TB treatment. By supporting a shorter treatment timeframe, offering the option for self-administration, and reducing treatment costs, cure of latent TB infection can be improved.
In 2010, Dr. Timothy Sterling led the PREVENT TB (Tuberculosis Trials Consortium Study 26), a multicenter randomized clinical trial, which tested the effectiveness of 3HP among persons with LTBI who were at high risk for progressing to active TB disease. Findings from this trial, and two other smaller trials led the Centers for Disease Control and Prevention to recommend use of 3HP for treating LTBI.
TB Centers of Excellence for Training, Education, and Medical Consultation
The TB COEs invite you to complete this online needs assessment to help identify your TB training, education, and medical consultation needs.  If you participate, your responses will be used to help shape the training, education, and medical consultation services offered by the TB COEs.
New Series by SNTC: When TB is the Least of Their Worries...
Corrections, 8/23 11a CT
Opiods, 9/13 11a CT
Upcoming Conferences
October 24-27, The Hague, The Netherlands

March 4-7, 2019, Seattle, WA. Abstract submission open August 30-September 27

March 8-10, 2019, Chicago, IL
Follow us on Twitter!
Subscribe to our email list.